A Weekly Shot Spared Three in Four Blood Cancer Patients from Repeat Blood Draws, and the FDA Just Approved It

FDA approved Mimrylo for polycythemia vera, the first hepcidin-mimicking drug for a blood cancer affecting about 90,000 Americans.

Have A Referral?